Full Text View
Tabular View
No Study Results Posted
Related Studies
White Matter Fiber Tracking and Assessment of White Matter Integrity in the Cervical Spinal Cord
This study is enrolling participants by invitation only.
First Received: January 17, 2006   Last Updated: March 20, 2008   History of Changes
Sponsors and Collaborators: Weill Medical College of Cornell University
Cervical Spine Research Society
Information provided by: Weill Medical College of Cornell University
ClinicalTrials.gov Identifier: NCT00280306
  Purpose

White matter fiber tracking may provide a novel tool to assess the integrity of injured motor tracts in the cervical spine. It provides information about fiber directions which is not given by conventional MRI. White matter fiber tracking in the brain is used at several institutions, including our own medical college, for presurgical planning of tumor excision. We believe that the technical and clinical experience gained for the brain can be applied to fiber tracking in the cervical spine as well.


Condition
Spinal Cord Compression

U.S. FDA Resources
Study Type: Observational
Study Design: Case Control, Cross-Sectional
Official Title: White Matter Fiber Tracking and Assessment of White Matter Integrity in the Cervical Spinal Cord - Pilot Study

Further study details as provided by Weill Medical College of Cornell University:

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 35
Study Start Date: November 2005
Estimated Study Completion Date: October 2008
Estimated Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
Detailed Description:

White matter fiber tracking may provide a novel tool to assess the integrity of injured motor tracts in the cervical spine. It provides information about fiber directions which is not given by conventional MRI. White matter fiber tracking in the brain is used at several institutions, including our own medical college, for presurgical planning of tumor excision. We believe that the technical and clinical experience gained for the brain can be applied to fiber tracking in the cervical spine as well. White matter fiber tracking in the cervical spine has some important clinical applications:

  • A better understanding of the relationship between abnormal cervical spinal anatomy and the impact on fiber tracts would be helpful in determining the best treatment for a particular patient. It may be able to define the indication and role of surgical decompression and stabilization based on quantifiable and reproducible data obtained with this new imaging technology.
  • It could help the surgeon to determine what type of surgical approach to choose (anterior versus posterior surgery, depending on the degree of compression / impingement on nerve fibers).
  • Correlation between quantitative diffusion measures and spinal cord injury may be used in monitoring the response to treatment and may therefore be an important parameter for clinicians to follow.
  • White matter fiber tracking may also help to determine the pathophysiology underlying cervical spondylotic myelopathy. Currently, there is a debate as to whether cervical spondylitic myelopathy is caused mainly by compressive narrowing of the spinal canal, which may lead to focal ischemia and tissue injury, or whether excessive motion due to cervical spondylosis results in increased strain and shear of spinal axons resulting in injury (Henderson et al., Neurosurgery 56(5):1101-13, 2005). If the latter is correct one would expect diffusion changes along the course of white matter tracks above and below the spondylotic changes.

We will first study a pool of 15 normal control subjects to refine our data acquisition and postprocessing tools, and to sample quantitative diffusion based data for the normal cervical spine. A second group of subjects will include 10 patients with significant cervical spondylosis and upper extremity radiculopathy without myelopathy. The third group will be 10 patients with cervical spondylosis and signs and symptoms of myelopathy. The two patient groups will allow us to define systematic differences between normal values and values in the injured spine.

The DTI data will be processed using tools for artifact correction first and then tools for rendering T2 weighted images, diffusion weighted images, ADC maps and FA values.

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Cervical spinal cord compression

Criteria

Inclusion Criteria:

Normal controls Spinal cord injury

Exclusion Criteria:

N/A

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00280306

Locations
United States, New York
Weill Medical College of Cornell
New York, New York, United States, 10021
Sponsors and Collaborators
Weill Medical College of Cornell University
Cervical Spine Research Society
Investigators
Principal Investigator: Henning U Voss Weill Medical College of Cornell
  More Information

No publications provided

Responsible Party: Weill Cornell Medical College ( Henning U. Voss, PhD, Assistant Professor of Physics in Radiology )
Study ID Numbers: 1-Voss
Study First Received: January 17, 2006
Last Updated: March 20, 2008
ClinicalTrials.gov Identifier: NCT00280306     History of Changes
Health Authority: United States: Institutional Review Board

Study placed in the following topic categories:
Spinal Cord Injuries
Spinal Cord Diseases
Spinal Cord Compression
Wounds and Injuries
Disorders of Environmental Origin
Central Nervous System Diseases

Additional relevant MeSH terms:
Spinal Cord Injuries
Spinal Cord Diseases
Spinal Cord Compression
Nervous System Diseases
Wounds and Injuries
Disorders of Environmental Origin
Central Nervous System Diseases

ClinicalTrials.gov processed this record on May 07, 2009